相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Expression and co-expression of serotonin and dopamine transporters in social anxiety disorder: a multitracer positron emission tomography study
Olof R. Hjorth et al.
MOLECULAR PSYCHIATRY (2021)
Placebo Effect in the Treatment of Depression and Anxiety
Irving Kirsch
FRONTIERS IN PSYCHIATRY (2019)
Efficacy of selective serotonin reuptake inhibitors in the absence of side effects: a mega-analysis of citalopram and paroxetine in adult depression
F. Hieronymus et al.
MOLECULAR PSYCHIATRY (2018)
Do You Believe It? Verbal Suggestions Influence the Clinical and Neural Effects of Escitalopram in Social Anxiety Disorder: A Randomized Trial
Vanda Faria et al.
EBIOMEDICINE (2017)
Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression
F. Hieronymus et al.
MOLECULAR PSYCHIATRY (2016)
Reduced serotonin synthesis and regional cerebral blood flow after anxiolytic treatment of social anxiety disorder
Andreas Frick et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)
Are antidepressants effective? A debate on their efficacy for the treatment of major depression in adults
Tom Bschor et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)
Reward functions of the basal ganglia
Wolfram Schultz
JOURNAL OF NEURAL TRANSMISSION (2016)
Are antidepressants effective? A debate on their efficacy for the treatment of major depression in adults
Tom Bschor et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)
Altered serotonin and dopamine transporter availabilities in brain of depressed patients upon treatment with escitalopram: A [123I]β-CIT SPECT study
A. Rominger et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
Serotonin Synthesis and Reuptake in Social Anxiety Disorder A Positron Emission Tomography Study
Andreas Frick et al.
JAMA PSYCHIATRY (2015)
Regional differences in SERT occupancy after acute and prolonged SSRI intake investigated by brain PET
Pia Baldinger et al.
NEUROIMAGE (2014)
The Efficacy of Paroxetine and Placebo in Treating Anxiety and Depression: A Meta-Analysis of Change on the Hamilton Rating Scales
Michael A. Sugarman et al.
PLOS ONE (2014)
Psychological and pharmacological interventions for social anxiety disorder in adults: a systematic review and network meta-analysis
Evan Mayo-Wilson et al.
LANCET PSYCHIATRY (2014)
Dopamine agonist-responsive depression
Hiroaki Hori et al.
PSYCHOGERIATRICS (2013)
Dopamine transporter binding in social anxiety disorder: the effect of treatment with escitalopram
J. M. Warwick et al.
METABOLIC BRAIN DISEASE (2012)
The mesoaccumbens dopamine in coping with stress
Simona Cabib et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2012)
Novel study designs to investigate the placebo response
Paul Enck et al.
BMC MEDICAL RESEARCH METHODOLOGY (2011)
The Effect of Treatment Expectation on Drug Efficacy: Imaging the Analgesic Benefit of the Opioid Remifentanil
Ulrike Bingel et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Serotonin Transporters in Dopamine Transporter Imaging: A Head-to-Head Comparison of Dopamine Transporter SPECT Radioligands I-123-FP-CIT and I-123-PE2I
Morten Ziebell et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Dopaminergic challenges in social anxiety disorder: evidence for dopamine D-3 desensitisation following successful treatment with serotonergic antidepressants
S. D. Hood et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
Unfaithful neurotransmitter transporters: Focus on serotonin uptake and implications for antidepressant efficacy
Lynette C. Daws
PHARMACOLOGY & THERAPEUTICS (2009)
Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses
David J. Scott et al.
ARCHIVES OF GENERAL PSYCHIATRY (2008)
Initial severity and antidepressant benefits: A meta-analysis of data submitted to the food and drug administration
Irving Kirsch et al.
PLOS MEDICINE (2008)
Effect of antidepressant drugs on 6-OHDA-treated mice in the FST
F. Chenu et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2007)
Effects of expectation on the brain metabolic responses to methylphenidate and to its placebo in non-drug abusing subjects
Nora D. Volkow et al.
NEUROIMAGE (2006)
Imaging of serotonin transporters and its blockade by citalopram in patients with major depression using a novel SPECT ligand [123I]-ADAM
N Herold et al.
JOURNAL OF NEURAL TRANSMISSION (2006)
Serotonin transporter residual availability during long-term antidepressant therapy does not differentiate responder and nonresponder unipolar patients
J Cavanagh et al.
BIOLOGICAL PSYCHIATRY (2006)
SERT and DAT availabilities under citalopram treatment in obsessive-compulsive disorder (OCD)
O Pogarell et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2005)
Validation of [121I]β-CIT SPECT to assess serotonin transporters in vivo in humans:: a double-blind, placebo-controlled, crossover study with the selective serotonin reuptake inhibitor citalopram
MML de Win et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Corelease of dopamine and serotonin from striatal dopamine terminals
FM Zhou et al.
NEURON (2005)
MR-based automatic delineation of volumes of interest in human brain PET images using probability maps
C Svarer et al.
NEUROIMAGE (2005)
Tryptophan depletion reverses the therapeutic effect of selective serotonin reuptake inhibitors in social anxiety disorder
SV Argyropoulos et al.
BIOLOGICAL PSYCHIATRY (2004)
Serotonin transporter occupancy of five selective serotonin Reuptake inhibitors at different doses:: An [11C]DASB positron emission tomography study
JH Meyer et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe
A Hammers et al.
HUMAN BRAIN MAPPING (2003)
An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets
JA Maldjian et al.
NEUROIMAGE (2003)
Changes in human in vivo serotonin and dopamine transporter availabilities during chronic antidepressant administration
A Kugaya et al.
NEUROPSYCHOPHARMACOLOGY (2003)
R-fluoxetine increases extracellular DA, NE, as well as 5-HT in rat prefrontal cortex and hypothalamus: An in vivo microdialysis and receptor binding study
S Koch et al.
NEUROPSYCHOPHARMACOLOGY (2002)
Pharmacokinetics of selective serotonin reuptake inhibitors
C Hiemke et al.
PHARMACOLOGY & THERAPEUTICS (2000)